<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        9-883-16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        FLAGYL 500MG SCORED TABS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        METRONIDAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="sanofi-aventis" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            sanofi-aventis
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2218]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Sanofi Arabia Trading Co. Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            sanofi-aventis
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        P01AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group: anti-parasitic antibacterial antibiotics of the nitro-5-imidazoles family, ATC code: J01XD01 &ndash; P01AB01<br />This medicine is used to treat certain infections caused by sensitive germs (bacteria, parasites).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use FLAGYL 500 mg film-coated tablets<br />if you are allergic to metronidazole, to a medicinal product from the imidazole family (family of antibiotics to which metronidazole belongs) or any of the other ingredients of this medicine (listed in section 6).<br />if you are allergic (hypersensitive) to wheat because it contains wheat starch (gluten),<br />if the patient is a child under the age of 6 (see the section on &ldquo;Warnings and precautions&rdquo;).<br />Warnings and precautions<br />Talk to your doctor or pharmacist before taking FLAGYL 500 mg film-coated tablets. Before taking FLAGYL 500 mg film-coated tablets, tell your doctor if you have:<br />Neurological disorders,<br />Psychiatric disorders,<br />Blood disorders,<br />History of meningitis while receiving metronidazole treatment.<br />If you are about to have a blood test, tell the doctor or nurse who is doing this test that you are taking FLAGYL 500 mg film-coated tablets. This medicine may affect the results of some blood tests.<br />Tell your doctor immediately if any of the following occur during treatment with FLAGYL 500 mg film-coated tablets:<br />From the first dose, there is a risk of severe and sudden allergic reaction (anaphylactic shock, angioedema) possibly causing the following symptoms: tight chest, dizziness, nausea or fainting, or dizziness on standing up (see section 4). If these symptoms occur, stop taking this medicine because your life might be in danger, and immediately contact your doctor.<br />If, at the start of treatment, you observe redness all over the body with pustules, accompanied by fever, a serious reaction known as acute generalised exanthematous pustulosis should be suspected (see section 4). Inform your doctor immediately, as treatment must be stopped. If such a reaction occurs, you should never again take metronidazole alone or in combination with another active substance in the same medicine.<br />You should watch out for any potential signs or worsening of nervous disorders such as difficulty coordinating movements, dizziness (feeling like your &ldquo;head is spinning&rdquo;), confusion, seizures, difficulty speaking or walking, shakiness, involuntary eye movements, as well as other effects on the hands and feet such as tingling, pins and needles, feeling cold, numbness and reduced sense of touch. These disorders are generally reversible on stopping treatment. Therefore, it is important to stop the treatment and talk to your doctor immediately (see section 4).<br />From the very first doses of treatment, behavioural disorders that may put you at risk can occur, especially if you have had psychiatric disorders in the past. If this happens, you should stop taking the medicine and see a doctor (see section 4).<br />If you have had blood disorders in the past, or are receiving high-dose and/or long-term treatment, your doctor may prescribe regular blood tests to check your complete blood count.<br />Inform the doctor or analysis laboratory that you are taking this medicine if you have to have a medical laboratory test, as taking metronidazole may interfere with some laboratory test results (test for treponema) by triggering a false positive result (e.g. the Nelson test).<br />Cases of severe liver toxicity/acute liver failure, including cases with a fatal outcome in patients with Cockayne syndrome, have been reported with medicines containing metronidazole.<br />If you have Cockayne syndrome, your doctor must monitor your liver function frequently, both during and after your treatment with metronidazole.<br />Tell your doctor immediately and stop taking metronidazole, if you have the following symptoms:<br />Stomach ache, loss of appetite, nausea, vomiting, fever, feeling sick tiredness, jaundice, dark-coloured urine, putty coloured stools or itching.<br /><strong>Children</strong><br />The taking of tablets is contraindicated in children under 6 years of age because the tablet may go down the wrong way and cause choking. There are other pharmaceutical presentations with this antibiotic suitable for young children.<br />Talk to your doctor or pharmacist before taking FLAGYL 500 mg film-coated tablets.<br /><strong>Other medicines and FLAGYL 500 mg film-coated tablets</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br />In particular, tell your doctor if you are taking:<br />Medicines containing alcohol because of the risk of side effects such as redness of the face, feeling hot, vomiting and increased heart rate,<br />Busulfan (recommended for the treatment of certain blood diseases and to prepare for a bone marrow transplant),<br />Disulfiram (used to prevent relapse in alcohol-dependent patients),<br />Any medicine which could cause disturbances in the heart&rsquo;s rhythm (also called QT interval prolongation, visible on electrocardiogram), such as some antiarrhythmics (medicines used to treat cardiac rhythm disorders), some antibiotics and medicines used as first-line therapy in the management of psychoses (including delusions, hallucinations, paranoia or disordered thoughts),<br />Enzyme-inducing anticonvulsants (used in the treatment of epileptic seizures),<br />Rifampicin (recommended in the treatment of certain bacterial infections, including tuberculosis),<br />Lithium (used to treat mental illnesses),<br />5-fluorouracil (cancer medicine),<br />Oral blood thinners called vitamin K antagonists which are prescribed to prevent clots from forming.<br /><strong>FLAGYL 500 mg film-coated tablets with food and drink</strong><br />You should avoid drinking alcohol while taking this medicine due to the risk of side effects, such as redness of the face, feeling hot, vomiting and increased heart rate.<br /><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br />If necessary, this medicine may be taken during pregnancy. However, you must always ask your doctor or pharmacist for advice before taking it.<br />You should avoid breast-feeding while taking this medicine.<br /><strong>Driving and using machines</strong><br />Vehicle drivers and persons operating machinery should pay particular attention to the risks associated with the use of FLAGYL 500 mg film-coated tablets, such as dizziness (feeling like your &ldquo;head is spinning&rdquo;), confusion, hallucinations (seeing or hearing things that are not there), convulsions (convulsive seizures), or temporary vision problems (such as blurred or double vision).<br />If these symptoms occur, do not drive a vehicle or operate machinery.<br /><strong>FLAGYL 500 mg film-coated tablets contains gluten</strong><br />This medicine contains only very low levels of gluten (from wheat starch) and is very unlikely to cause problems if you have coeliac disease.<br />One tablet contains no more than 16.43 micrograms of gluten.<br />If you have wheat allergy (different from coeliac disease) you should not take this medicine (see the &ldquo;Do not use FLAGYL 500 mg film-coated tablets&rdquo; paragraph).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine is only for adults and children six years of age or older. In children under 6 years of age, there are pharmaceutical forms available which are more suitable.<br />The dosage depends on your age and the illness being treated.<br />As an indication, the usual dose is:<br />Adults: 0.750 g/day to 2 g/day,<br />Children: 500 mg/day to 20-40 mg/kg/day.<br />In some cases, it is essential that your partner be treated, whether or not he/she has any clinical signs of the same infection.<br />IN ALL CASES, FOLLOW YOUR DOCTOR&rsquo;S PRESCRIPTION.<br />Oral use.<br />Swallow the tablets with a glass of water.<br /><strong>Frequency of administration</strong><br />1 to 3 times a day depending on why you are taking this medicine.<br /><strong>Duration of treatment</strong><br />In order to be effective, this antibiotic must be taken regularly at the prescribed doses and for as long as your doctor advises.<br />If your fever or any other symptom disappears, it does not mean that you are cured. If you feel tired, this is not due to the antibiotic treatment but to the infection itself. Reducing or stopping your treatment would have no effect on this feeling and would only delay your recovery.<br />Special cases: treatment of giardiasis (infection caused by a parasite) should last 5 days, treatment of amoebiasis (infection caused by a parasite) and some types of vaginitis (infection of the vagina), 7 days and treatment of trichomoniasis (infection caused by a parasite) is a single dose treatment.<br /><strong>If you take more FLAGYL 500 mg film-coated tablets than you should</strong><br />Consult your doctor or pharmacist immediately.<br />If you are vomiting, have difficulty coordinating your movements or are disoriented, consult your doctor.<br />Your doctor may decide to prescribe appropriate treatment.<br /><strong>If you forget to take FLAGYL 500 mg film-coated tablets</strong><br />Not applicable.<br /><strong>If you stop taking FLAGYL 500 mg film-coated tablets</strong><br />Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br /><u><strong>Gastrointestinal disorders</strong></u><br />Gastrointestinal disorders that are not serious, such as stomach ache, nausea, vomiting, diarrhoea;<br />Inflammation of the tongue and dry mouth, inflammation of the mouth, taste disorders, loss of appetite;<br />Pancreatitis (inflammation of the pancreas), which is reversible on stopping treatment;<br />Discolouration or change in the appearance of the tongue (may be caused by fungal growth).<br /><u><strong>Skin and subcutaneous tissue disorders</strong></u><br />Hot flushes with redness of the face, itching, skin rashes sometimes accompanied by fever;<br />Urticaria (nettle-like skin rash), sudden swelling of the face and neck, caused by allergies (angioedema), life-threatening allergic shock (see section 2, paragraph &ldquo;Warnings and precautions&rdquo;);<br />Very rare cases of whole-body generalised redness with pustules and fever (acute generalised exanthematous pustulosis) (see section 2, paragraph &ldquo;Warnings and precautions&rdquo;);<br />Blister eruption with skin detachment that can spread throughout the body and endanger the patient (Lyell&rsquo;s syndrome, Stevens-Johnson syndrome);<br />Fixed pigmented erythema: skin rash with round, red patches with an itchy, burning sensation leaving coloured marks and possibly reappearing in the same places if treatment is resumed with the same medicine.<br /><u><strong>Nervous system disorders</strong></u><br />Nerve damage in the limbs (peripheral sensory neuropathy) with effects on the hands and feet such as tingling, pins and needles, feeling cold, numbness and reduced sense of touch;<br />Headache;<br />Dizziness (feeling like your &ldquo;head is spinning&rdquo;);<br />Seizures;<br />Confusion;<br />Neurological disorders, known as encephalopathy or cerebellar syndrome, with symptoms including confusion, consciousness disorders, behavioural disorders, difficulty coordinating movements, problems with pronunciation, gait disorders, involuntary eye movements, shakiness. These disorders are generally reversible on stopping treatment and may be associated with changes in MRI scans. Exceptional cases of fatal outcome have been reported (see section 2, paragraph &ldquo;Warnings and precautions&rdquo;);<br />Non-bacterial meningitis;<br /><u><strong>Psychiatric disorders</strong></u><br />Hallucinations;<br />Personality disorders (paranoia, delirium) that may be accompanied by suicidal ideation or acts (see section 2, paragraph &ldquo;Warnings and precautions&rdquo;);<br />Tendency to depression;<br /><u><strong>Eye disorders</strong></u><br />Temporary vision disorders, such as blurred vision, double vision, short-sightedness, decreased vision, changes in colour vision;<br />Optic nerve damage/inflammation;<br /><u><strong>Blood and lymphatic system disorders</strong></u><br />Abnormally low platelet counts, abnormally low or major drop in the number of certain white blood cells (neutrophils).<br /><u><strong>Cardiac disorders</strong></u><br />Frequency not known (cannot be estimated from the available data): disturbances in the heart&rsquo;s rhythm (also called QT interval prolongation, visible on electrocardiogram), particularly when FLAGYL 500 mg film-coated tablets are used with other medicines likely to cause disturbances in the heart&rsquo;s rhythm.<br /><u><strong>Hepatobiliary disorders</strong></u><br />Elevated liver enzymes (transaminases, alkaline phosphatases);<br />Very rare cases of serious liver disease (sometimes with jaundice), in particular cases of liver failure requiring a transplant.<br />Not known (cannot be estimated from the available data): acute liver failure in patients with Cockayne syndrome (see section 2, paragraph &ldquo;Warnings and precautions&rdquo;).<br /><u><strong>Others</strong></u><br />Reddish-brown coloured urine caused by the medicine.<br /><strong><u>Reporting of side effects</u><br />&bull; Saudi Arabia:</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p><u><strong>&bull; Sanofi- Pharmacovigilance: KSA_Pharmacovigilance@sanofi.com</strong></u></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not store above 30&deg;C<br />Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the box.<br />The expiry date refers to the last day of that month.<br />Store the blisters in their outer packaging, protected from light.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is:<br />Metronidazole ..................................................................................................................... 500.00 mg<br />For one film-coated tablet.<br />The other ingredients are:<br />Wheat starch, povidone K30, magnesium stearate, hypromellose, macrogol 20000.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicine comes in the form of film-coated tablets.
Boxes of 4 or 14.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong><br />Sanofi-Aventis France<br />82 Avenue Raspail<br />94250 Gentilly<br /><strong>Operator</strong><br />Sanofi-Aventis France<br />82 Avenue Raspail<br />94250 Gentilly , France<br /><strong>Manufacturer</strong><br />Sanofi-Aventis S.A.<br />Ctra. Ctra. C-35 (La Batll&ograve;ria-Hostalric, km. 63.09)<br />Riells I Viabrea<br />17404 Gerona, Spain<br /><strong>Secondary packaging</strong><br />Sanofi Aventis Arabia Co, Ltd<br />Industrial Valley Phase 1A St.<br />KAEC, Abdullahndustrial Valley<br />Phase 1A St, Rabigh,, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                April 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">المجموعة العلاجيّة الدوائيّة: المضادات الحيويّة المضادة للبكتيريا المضادة للطفيليّات من عائلة نيترو -5-إيميدازول، رمز التصنيف الكيميائي العلاجي التشريحي ATC: J01XD01 &ndash; P01AB01</p><p dir="RTL">يُستعمل هذا الدواء لعلاج بعض حالات العدوى التي تسبّبها جراثيم حسّاسة (البكتيريا والطفيليّات).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستعمل فلاجيل </strong><strong>500 ملغ، </strong><strong>أقراص مغلّفة بطبقة رقيقة</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بحساسيّة ضدّ المترونيدازول أو أيّ دواء ينتمي إلى مجموعة الإيميدازول (مجموعة المضادات الحيويّة التي تتضمّن المترونيدازول) أو أيّ من المكوّنات الأخرى في هذا الدواء (الواردة في القسم 6).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بحساسيّة (فرط حساسيّة) ضدّ القمح، لأنّ هذا الدواء يحتوي على نشا القمح (غلوتين).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان المريض طفلاً ما دون عمر الستّ سنوات (راجع فقرة &quot;تحذيرات واحتياطات&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">تحدّث إلى طبيبك أو الصيدلي قبل أن تأخذ فلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة.</p><p dir="RTL">قبل أخذ فلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة<strong>، </strong>أعلم طبيبك إذا كنت تعاني من:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات عصبيّة،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات نفسيّة،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في الدم،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصبت سابقًا بالتهاب السحايا في خلال فترة العلاج بالمترونيدازول.&nbsp; <strong>&nbsp;</strong></p><p dir="RTL">إذا كنت على وشك إجراء فحص دم، أعلم الطبيب أو الممرّضة التي تجري هذا الفحص أنك تتناول فلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة. قد يؤثر هذا الدواء على نتائج بعض تحاليل الدم.</p><p dir="RTL">أعلم طبيبك على الفور إذا حدث أيّ مما يلي أثناء العلاج بفلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة:</p><p dir="RTL">من الجرعة الأولى، تواجه خطر التعرّض لارتكاس تحسسي حاد ومفاجئ (صدمة تأقيّة، خزب وعائي) قد يسبّب العوارض التالية: ضيق في الصّدر، دوار، غثيان أو إغماء، أو دوار عند الوقوف (راجع القسم 4). في حال حصول هذه العوارض، توقّف عن أخذ هذا الدواء لأنّ حياتك قد تكون في خطر واتصل بالطبيب على الفور.</p><p dir="RTL">في حال أصبت في بداية العلاج باحمرار أو بانتشار بثور على جسمك كلّه، مع حمى، يجب الشكّ بإصابتك بارتكاس خطير يُعرف بالبُثار الطفحي المعمّم (راجع القسم 4). أعلم طبيبك على الفور لأنّه يجب إيقاف العلاج. وفي حال حصول هذا الارتكاس، يُمنع أيّ استعمال آخر للمترونيدازول لوحده أو بالاشتراك مع مادة فعالة أخرى في الدواء ذاته.</p><p dir="RTL">يجب أن تنتبه في حال حصول أيّ إشارات محتملة أو تفاقم لاضطرابات عصبيّة مثل صعوبة في تنسيق الحركات أو دوار (الشعور بأنّ &quot;رأسك يدور&quot;) أو إرتباك، أو نوبات صرع، أو صعوبة في الكلام أو السير، أو رجفة أو حركات غير إراديّة في العينين وكذلك تأثيرات أخرى على اليدين والقدمين مثل التنمّل والوخز والشعور بالبرد والخدر وضعف حاسّة اللمس. تزول هذه الاضطرابات عادة عند إيقاف العلاج. لذلك من المهمّ إيقاف العلاج واستشارة الطبيب على الفور (راجع القسم 4). &nbsp;</p><p dir="RTL">من الجرعات الأولى، يمكن أن تحدث اضطرابات سلوكيّة قد تعرّضك للخطر، بخاصة إذا عانيت في السابق من اضطرابات نفسيّة. في هذه الحالة، يجب عليك التوقّف عن أخذ الدواء ومراجعة الطبيب (راجع القسم 4).</p><p dir="RTL">في حال عانيت في السابق من اضطرابات في الدم أو تلقّيت علاجًا عالي الجرعة و/أو طويل الأمد، قد يصف لك طبيبك فحوصات دم عاديّة للتحقق من تعدادك الدموي الكامل.</p><p dir="RTL">أعلم الطبيب أو مختبر التحليل أنّك تأخذ هذا الدواء إذا كان عليك الخضوع لفحص مخبريّ طبي، فأخذ المترونيدازول قد يتداخل مع بعض نتائج الفحوصات المخبريّة (فحص اللولبيّة)، عبر إطلاق نتيجة إيجابيّة خاطئة لفحص معيّن (مثل فحص نلسون).</p><p dir="RTL">تمّ الإبلاغ عن حالات تسمّم حاد في الكبد / فشل كبدي حاد، بما في ذلك حالات سببت الوفاة لدى مرضى يعانون من متلازمة كوكاين، مع أدوية تحتوي على الميترونيدازول.</p><p dir="RTL">إذا كنت تعاني من متلازمة كوكاين، يجب على طبيبك مراقبة وظائف الكبد لديك بشكل متكرر، أثناء العلاج بالميترونيدازول وبعده.</p><p dir="RTL">أعلم طبيبك على الفور وتوقّف عن تناول الميترونيدازول، إذا كنت تعاني من الأعراض التالية:</p><p dir="RTL">آلام في المعدة، فقدان الشهيّة، غثيان، قيء، حمى، شعور بالغثيان، إرهاق، يرقان، بول داكن اللون، براز ملوّن أو حكّة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">يُمنع إعطاء الأقراص للأطفال ما دون السادسة من العمر لأنّ القرص قد يذهب في الاتجاه الخاطئ ويسبّب الاختناق. توجد أشكال دوائيّة أخرى من المضاد الحيوي هذا مناسبة للأطفال الصغار.</p><p dir="RTL">تحدّث إلى الطبيب أو الصيدلي قبل أخذ فلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أدوية أخرى وفلاجيل 500 ملغ، </strong><strong>أقراص مغلّفة بطبقة رقيقة</strong><strong>&nbsp; </strong></p><p dir="RTL">أعلم الطبيب أو الصيدلي إذا كنت تأخذ حاليًا أو أخذت مؤخّرًا أو قد تأخذ أيّ أدوية أخرى.</p><p dir="RTL">بصورة خاصّة، أعلم الطبيب إذا كنت تأخذ:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية تحتوي على الكحول بسبب خطر التعرّض لتأثيرات جانبيّة مثل احمرار الوجه والشعور بالحرّ والتقيّؤ وزيادة سرعة القلب،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البوسولفان (الذي يوصف لعلاج بعض أنواع أمراض الدم ولتحضير زرع نقيّ العظم)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الديسولفيرام (المستعمل لمنع الانتكاس لدى المرضى المدمنين على الكحول).&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أيّ دواء يمكن أن يسبّب اضطرابات في ضربات القلب (وتُسمّى أيضًا إطالة فترة كيو تيQT ، تظهر في مخطط القلب الكهربائي)، مثل بعض مضادات عدم انتظام ضربات القلب (الأدوية المستعملة لعلاج اضطرابات ضربات القلب)، وبعض المضادات الحيويّة والأدوية المستعملة كعلاج الخط الأوّل في علاج الذُهان (بما في ذلك الأوهام والهلوسة والبارانويا أو الأفكار المضطربة)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الاختلاج التي تحفّز الإنزيمات (المستعملة في علاج نوبات الصرع)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الريفامبيسين (يوصى به في علاج بعض أنواع العدوى البكتيريّة، بما في ذلك السلّ)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الليثيوم (يُستعمل لعلاج الأمراض العقلية)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5-فلورويوراسيل (دواء للسرطان)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مميّعات الدم التي تؤخذ عن طريق الفم وتُسّمى مضادات فيتامين ك والتي توصف لمنع تشكّل الجلطات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>فلاجيل 500 ملغ، </strong><strong>أقراص مغلّفة بطبقة رقيقة</strong><strong> مع الطعام والشراب </strong></p><p dir="RTL">يجب تفادي استهلاك الكحول في خلال فترة العلاج بهذا الدواء بسبب خطر التعرّض لتأثيرات جانبيّة مثل احمرار الوجه والشعور بالحرّ والتقيّؤ وزيادة سرعة القلب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والإرضاع</strong></p><p dir="RTL">إذا كنتِ حاملاً أو مرضعة أو كنت تعتقدين نفسك حاملاً أو كنتِ تنوين الحمل، يجب عليك دائمًا استشارة الطبيب أو الصيدلي قبل أخذ هذا الدواء.</p><p dir="RTL">عند الضرورة، يمكن أخذ هذا الدواء في خلال فترة الحمل. ولكن يجب عليك دائمًا استشارة الطبيب أو الصيدلي قبل أخذه.</p><p dir="RTL">عليك تفادي الإرضاع في خلال فترة العلاج بهذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قيادة السيّارات واستعمال الآلات</strong></p><p dir="RTL">يجب على سائقي السيّارات والأشخاص الذين يقومون بتشغيل الآلات إيلاء اهتمام خاص للمخاطر المرتبطة باستخدام فلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة، مثل الدوار (الشعور بأنّ &quot;رأسك يدور&quot;)، والارتباك، والهلوسة (رؤية أو سماع أشياء غير موجودة)، أو تشنّجات (نوبات تشنجيّة)، أو مشاكل مؤقتة في الرؤية (مثل عدم وضوح الرؤية أو ازدواجها).</p><p dir="RTL">في حالة حدوث هذه الأعراض، لا يجوز قيادة السيّارة أو تشغيل الآلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يحتوي فلاجيل 500 ملغ، </strong><strong>أقراص مغلّفة بطبقة رقيقة على الغلوتين</strong></p><p dir="RTL">يحتوي هذا الدواء على مستويات منخفضة جدًا من الغلوتين (من نشا القمح) ومن غير المرجّح أن يسبّب مشاكل إذا كنت تعاني من مرض الاضطرابات الهضميّة.</p><p dir="RTL">لا يحتوي قرص واحد على أكثر من 16.43 ميكروغرام من الغلوتين.</p><p dir="RTL">إذا كنت تعاني من حساسية القمح (تختلف عن مرض الاضطرابات الهضميّة)، فلا ينبغي أن تتناول هذا الدواء (انظر فقرة &quot;لا تستعمل فلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة&quot;).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">هذا الدواء هو فقط للبالغين وللأطفال في السادسة من العمر وما فوق. تتوافر للأطفال ما دون السادسة من العمر أشكال دوائيّة تناسبهم أكثر.</p><p dir="RTL">يتوقّف مقدار الجرعة على عمرك وعلى المرض المعالج.</p><p dir="RTL">على سبيل الإشارة، يبلغ مقدار الجرعة العاديّة:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لدى البالغين: 0.750 غ/اليوم إلى 2 غ/اليوم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لدى الأطفال: 500 ملغ/اليوم إلى 20-40 ملغ/كلغ/اليوم.</p><p dir="RTL">في بعض الحالات، من الضروري أن يُعالج شريكك/شريكتك، أكان لديه/لديها إشارات سريريّة للعدوى ذاتها أو لا.</p><p dir="RTL">في مطلق الأحوال، تقيّد بوصفة طبيبك.</p><p dir="RTL">عن طريق الفم.</p><p dir="RTL">إبلع الأقراص مع كوب من الماء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>عدد مرّات الاستعمال </strong></p><p dir="RTL">من مرّة إلى 3 مرّات في اليوم حسب العدوى التي تأخذ من أجلها هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>مدّة العلاج&nbsp; </strong></p><p dir="RTL">لكي يكون المضاد الحيوي هذا فعّالاً، يجب استعماله بانتظام حسب الجرعات الموصوفة وللمدّة التي يحدّدها الطبيب.</p><p dir="RTL">لا يعني اختفاء الحرارة أو أيّ عارض آخر أنّك شفيت. فأيّ شعور بالتعب لا يعود إلى العلاج بالمضاد الحيوي ولكن إلى حالة العدوى نفسها. لذلك لن يؤثّر تخفيض الجرعة أو إيقاف العلاج على هذا الشعور وسوف يؤخّر شفاءك.&nbsp;&nbsp;</p><p dir="RTL">حالات خاصة: يجب أن يدوم علاج داء الجيارديّات (عدوى يسبّبها طفيليّ) لخمسة أيّام، وعلاج داء الأميبة (عدوى يسبّبها طفيليّ) وبعض أنواع التهاب المهبل (عدوى في المهبل) 7 أيّام وعلاج داء المشعّرات (عدوى يسبّبها طفيليّ) يتمّ بجرعة وحيدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا أخذت جرعة مفرطة من فلاجيل 500 ملغ، </strong><strong>أقراص مغلّفة بطبقة رقيقة</strong></p><p dir="RTL">استشر الطبيب أو الصيدلي على الفور.</p><p dir="RTL">إذا كنت تتقيّأ أو تواجه صعوبة في تنسيق حركاتك أو تشعر بالتهيان، استشر الطبيب الذي قد يقرّر وصف علاج مناسب لك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت أخذ فلاجيل 500 ملغ، </strong><strong>أقراص مغلّفة بطبقة رقيقة </strong></p><p dir="RTL">لا ينطبق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن استعمال فلاجيل 500 ملغ، </strong><strong>أقراص مغلّفة بطبقة رقيقة </strong></p><p dir="RTL">لا ينطبق.</p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype id="_x0000_t202"
  coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="Text_x0020_Box_x0020_7" o:spid="_x0000_s1026"
  type="#_x0000_t202" style='position:absolute;left:0;text-align:left;
  margin-left:80.8pt;margin-top:12pt;width:464.15pt;height:127.65pt;z-index:-251657216;
  visibility:visible;mso-wrap-style:square;mso-width-percent:0;
  mso-height-percent:0;mso-wrap-distance-left:0;mso-wrap-distance-top:0;
  mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;
  mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
  mso-position-vertical:absolute;mso-position-vertical-relative:text;
  mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
  mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" strokeweight=".58pt">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoBodyText dir=RTL style='margin-top:2.7pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l4 level1 lfo2;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
     Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></i><![endif]><span
     dir=RTL></span><span lang=AR-SA style='font-size:12.0pt;line-height:115%;
     font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>المركز
     الوطني للتيقّظ والسلامة الدوائيّة:</span><i><span dir=LTR
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></i></p>
     <p class=MsoBodyText dir=RTL style='margin-top:2.7pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l2 level1 lfo3;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:Calibri'><span style='mso-list:Ignore'>-<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span></i><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>فاكس: </span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span dir=LTR></span>+966-11-205-7662<i><o:p></o:p></i></span></p>
     <p class=MsoListParagraphCxSpFirst dir=RTL style='margin-top:0in;
     margin-right:22.3pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;
     mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo3;
     tab-stops:22.3pt;mso-layout-grid-align:none;text-autospace:none;
     direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
     style='font-size:12.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     Calibri;mso-ansi-language:EN-US;mso-fareast-language:EN-US'><span
     style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>رقم
     الاتصال بالمركز الوطني للتيقّظ والسلامة الدوائيّة: </span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=LTR></span>+966-11-2038222</span><span dir=RTL></span><span
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     dir=RTL></span> <span lang=AR-SA>الأرقام الداخليّة: </span></span><span
     dir=LTR></span><span dir=LTR style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=LTR></span>2317-2356-2353-2354-2334-2340</span><span
     dir=RTL></span><span style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=RTL></span> </span><span dir=LTR style='font-size:12.0pt;
     font-family:"Calibri",sans-serif;mso-ascii-theme-font:minor-latin;
     mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
     mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;
     mso-ansi-language:EN-US;mso-fareast-language:EN-US'><o:p></o:p></span></p>
     <p class=MsoListParagraphCxSpLast dir=RTL style='margin-top:0in;
     margin-right:22.3pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;
     mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo3;
     tab-stops:22.3pt;mso-layout-grid-align:none;text-autospace:none;
     direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
     style='font-size:12.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     Calibri;mso-ansi-language:EN-US;mso-fareast-language:EN-US'><span
     style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
     EN-US;mso-fareast-language:EN-US'>الهاتف المجاني: </span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=LTR></span>8002490000</span><span dir=LTR
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
     EN-US;mso-fareast-language:EN-US'><o:p></o:p></span></p>
     <p class=MsoBodyText dir=RTL style='margin-top:2.7pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l2 level1 lfo3;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:Calibri'><span style='mso-list:Ignore'>-<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span></i><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>البريد الإلكتروني: </span><a
     href="mailto:npc.drug@sfda.gov.sa%20"><span lang=FR dir=LTR
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi;mso-ansi-language:FR;mso-bidi-font-style:
     italic'>npc.drug@sfda.gov.sa </span></a><span class=MsoHyperlink><span
     lang=FR dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi;mso-ansi-language:FR;mso-bidi-font-style:
     italic'><span style='mso-spacerun:yes'> </span></span></span><i><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></i></p>
     <p class=MsoBodyText dir=RTL style='margin-top:.25pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l2 level1 lfo3;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:Calibri'><span style='mso-list:Ignore'>-<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span></i><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>الموقع الإلكتروني:</span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin'><span dir=LTR></span> www.sfda.gov.sa/npc</span><i><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></i></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left" style="width:1003.4px"><tbody><tr><td style="width:1px">&nbsp;</td></tr><tr><td style="width:1px">&nbsp;</td><td style="width:1003.6px">&nbsp;</td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل الأدوية كلّها، قد يسبّب هذا الدواء<strong> </strong>تأثيرات جانبيّة لا تُصيب المرضى كلّهم.</p><p dir="RTL"><strong><u>إضطرابات معديّة معويّة</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات معديّة معويّة ليست خطيرة، مثل&nbsp; أوجاع المعدة والغثيان والتقيّؤ والإسهال،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إلتهاب اللسان وجفاف الفم، التهاب الفم، اضطرابات في حاسة الذوق، فقدان الشهيّة،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إلتهاب البنكرياس (التهاب في البنكرياس) لكنّه يزول بعد إيقاف العلاج،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيّر لون اللسان أو تغيير في مظهره (قد يكون السبب نموًّا فطريًا).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>اضطرابات الجلد والأنسجة تحت الجلد</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هبو مع احمرار الوجه، حكّة، طفح جلدي مع حمى أحيانًا،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شرى (طفح جلدي شبيه بطفح القرّاص)، تورّم مفاجئ في الوجه والعنق بسبب حساسيّات (خزب وعائي) وصدمة إرجيّة تهدّد الحياة (راجع في القسم 2 فقرة &quot;تحذيرات واحتياطات&quot;)،&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات نادرة جدًا من الاحمرار الذي ينتشر على الجسم كلّه مع بثور ومع حمى (البُثار الطفحي المعمّم الحاد) (راجع في القسم 2 فقرة &quot;تحذيرات واحتياطات&quot;). &nbsp;&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن ينتشر على الجسم كلّه بسرعة طفح بثاري مع تقشّر الجلد وأن يهدّد الحياة (متلازمة ليل، متلازمة ستيفنز-حونسون).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمامي مصطبغة ثابتة: طفح جلدي مع بقع حمراء مستديرة مع حكّة وحرقان يترك علامات ملوّنة وربما تظهر مرة أخرى في الأماكن ذاتها إذا تمّ استئناف العلاج بالدواء ذاته.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>إضطرابات الجهاز العصبي</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضرر&nbsp; في أعصاب الأطراف (اعتلال عصبي حسّي محيطي) مع تأثيرات على اليدين والقدمين مثل التنمّل والوخز والشعور بالبرد والخدر وضعف حاسّة اللمس،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار (الشعور بأنّ &quot;رأسك يدور&quot;)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات صرع،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشوّش ذهني،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات عصبيّة، تُعرف بالاعتلال الدماغي أو متلازمة المخيخ، مع أعراض تتضمّن التشوّش الذهني واضطرابات في الوعي واضطرابات في السلوك وصعوبة في تنسيق الحركات واضطرابات في اللفظ واضطرابات في المشية وحركات غير إراديّة في العينين ورجفة. عادة ما تزول هذه الاضطرابات عند إيقاف العلاج وقد تترافق مع تغييرات في فحوصات الرنين المغنطيسي. أفيد عن حالات نادرة جدًا من الوفيّات (راجع في القسم 2 فقرة &quot;تحذيرات واحتياطات&quot;)،&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب السحايا غير البكتيري.</p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>اضطرابات نفسيّة</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هلوسات،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في الشخصيّة (بارانويا، هذيان) يُحتمل أن تترافق مع أفكار انتحاريّة أو محاولات انتحار (راجع في القسم 2 فقرة &quot;تحذيرات واحتياطات&quot;)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميول اكتئابيّة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong><u>اضطرابات في الرؤية</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات مؤقتة في الرؤية مثل عدم وضوح الرؤية وازدواج الرؤية وقصر النظر وضعف النظر وتغييرات في رؤية الألوان،</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>تلف / التهاب العصب البصري.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>اضطرابات الدم والجهاز الليمفاوي</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض غير طبيعي في تعداد صفيحات الدم، وانخفاض غير طبيعي أو هبوط كبير في عدد بعض خلايا الدم البيض (العدلات).&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>اضطرابات القلب</u></strong></p><p dir="RTL">معدّل حصول غير معروف (لا يمكن تقديره من البيانات المتاحة): اضطرابات في إيقاع القلب (تسمى أيضًا إطالة فترة كيو تي، تظهر في مخطط القلب الكهربائي)، بخاصة عند استعمال فلاجيل 500 ملغ، أقراص مغلّفة بطبقة رقيقة مع أدوية أخرى من المحتمل أن تسبب اضطرابات في إيقاع القلب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>الاضطرابات الكبديّة الصفراويّة</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع انزيمات الكبد (ناقلات الأمين، الفوسفاتاز القلوي)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات نادرة جدًا من من مرض الكبد الخطير (يترافق مع يرقان أحيانًا)، بخاصة حالات من قصور الكبد الذي يتطلّب زرعًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تأثيرات غير معروفة معدّل الحصول (لا يمكن تقديرها من البيانات المتاحة): فشل الكبد الحاد لدى مرضى متلازمة كوكاين (راجع في القسم 2 فقرة &quot;تحذيرات واحتياطات&quot;).</p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>تأثيرات أخرى</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تلوّن البول بالبنّي المائل إلى الاحمرار بسبب الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>للإبلاغ عن التأثيرات الجانبيّة</u></strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المملكة العربيّة السعوديّة:</strong><br /><!--[if gte vml 1]><o:wrapblock><v:shapetype id="_x0000_t202"
  coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="Text_x0020_Box_x0020_7" o:spid="_x0000_s1026"
  type="#_x0000_t202" style='position:absolute;left:0;text-align:left;
  margin-left:80.8pt;margin-top:197.25pt;width:464.15pt;height:127.65pt;
  z-index:-251657216;visibility:visible;mso-wrap-style:square;
  mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:0;
  mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;
  mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
  mso-position-vertical:absolute;mso-position-vertical-relative:text;
  mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
  mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" strokeweight=".58pt">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoBodyText dir=RTL style='margin-top:2.7pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l8 level1 lfo9;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:
     Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></i><![endif]><span
     dir=RTL></span><span lang=AR-SA style='font-size:12.0pt;line-height:115%;
     font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>المركز
     الوطني للتيقّظ والسلامة الدوائيّة:</span><i><span dir=LTR
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></i></p>
     <p class=MsoBodyText dir=RTL style='margin-top:2.7pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l6 level1 lfo10;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:Calibri'><span style='mso-list:Ignore'>-<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span></i><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>فاكس: </span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span dir=LTR></span>+966-11-205-7662<i><o:p></o:p></i></span></p>
     <p class=MsoListParagraphCxSpFirst dir=RTL style='margin-top:0in;
     margin-right:22.3pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;
     mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l6 level1 lfo10;
     tab-stops:22.3pt;mso-layout-grid-align:none;text-autospace:none;
     direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
     style='font-size:12.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     Calibri;mso-ansi-language:EN-US;mso-fareast-language:EN-US'><span
     style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>رقم
     الاتصال بالمركز الوطني للتيقّظ والسلامة الدوائيّة: </span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=LTR></span>+966-11-2038222</span><span dir=RTL></span><span
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     dir=RTL></span> <span lang=AR-SA>الأرقام الداخليّة: </span></span><span
     dir=LTR></span><span dir=LTR style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=LTR></span>2317-2356-2353-2354-2334-2340</span><span
     dir=RTL></span><span style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=RTL></span> </span><span dir=LTR style='font-size:12.0pt;
     font-family:"Calibri",sans-serif;mso-ascii-theme-font:minor-latin;
     mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
     mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;
     mso-ansi-language:EN-US;mso-fareast-language:EN-US'><o:p></o:p></span></p>
     <p class=MsoListParagraphCxSpLast dir=RTL style='margin-top:0in;
     margin-right:22.3pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;
     mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l6 level1 lfo10;
     tab-stops:22.3pt;mso-layout-grid-align:none;text-autospace:none;
     direction:rtl;unicode-bidi:embed'><![if !supportLists]><span
     style='font-size:12.0pt;font-family:"Calibri",sans-serif;mso-fareast-font-family:
     Calibri;mso-ansi-language:EN-US;mso-fareast-language:EN-US'><span
     style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
     EN-US;mso-fareast-language:EN-US'>الهاتف المجاني: </span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;
     mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
     EN-US'><span dir=LTR></span>8002490000</span><span dir=LTR
     style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;mso-ansi-language:
     EN-US;mso-fareast-language:EN-US'><o:p></o:p></span></p>
     <p class=MsoBodyText dir=RTL style='margin-top:2.7pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l6 level1 lfo10;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:Calibri'><span style='mso-list:Ignore'>-<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span></i><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>البريد الإلكتروني: </span><a
     href="mailto:npc.drug@sfda.gov.sa%20"><span lang=FR dir=LTR
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi;mso-ansi-language:FR;mso-bidi-font-style:
     italic'>npc.drug@sfda.gov.sa </span></a><span class=MsoHyperlink><span
     lang=FR dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi;mso-ansi-language:FR;mso-bidi-font-style:
     italic'><span style='mso-spacerun:yes'> </span></span></span><i><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></i></p>
     <p class=MsoBodyText dir=RTL style='margin-top:.25pt;margin-right:22.3pt;
     margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:right;
     text-indent:-.25in;line-height:115%;mso-pagination:none;mso-list:l6 level1 lfo10;
     tab-stops:22.3pt;mso-layout-grid-align:auto;direction:rtl;unicode-bidi:
     embed'><![if !supportLists]><i style='mso-ansi-font-style:normal'><span
     style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-fareast-font-family:Calibri'><span style='mso-list:Ignore'>-<span
     style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span></i><![endif]><span dir=RTL></span><span lang=AR-SA
     style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>الموقع الإلكتروني:</span><span dir=LTR></span><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Calibri",sans-serif;
     mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;
     mso-bidi-theme-font:minor-latin'><span dir=LTR></span> www.sfda.gov.sa/npc</span><i><span
     dir=LTR style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></i></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>المركز الوطني للتيقّظ والسلامة الدوائيّة:</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>فاكس: +966-11-205-7662</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رقم الاتصال بالمركز الوطني للتيقّظ والسلامة الدوائيّة: +966-11-2038222 الأرقام الداخليّة: 2317-2356-2353-2354-2334-2340</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهاتف المجاني: 8002490000</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>البريد الإلكتروني: npc.drug@sfda.gov.sa &nbsp;</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الموقع الإلكتروني: www.sfda.gov.sa/npc</p><p>&nbsp;</p></td></tr></tbody></table><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>سانوفي- التيقّظ الدوائي:&nbsp; KSA_Pharmacovigilance@sanofi.com</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إحفظ الدواء في درجة حرارة لا تتجاوز 30 درجة مئويّة.</p><p dir="RTL">إحفظ الدواء بعيدًا عن نظر الأطفال ومتناولهم.</p><p dir="RTL">لا تستعمل هذا الدواء بعد انقضاء تاريخ الصلاحيّة المدوّن على العبوة.</p><p dir="RTL">إحفظ الظروف في الغلاف الخارجي بعيدًا عن النور.</p><p dir="RTL">لا ترمِ أيّ أدوية في مياه الصرف الصحّي أو مع النفايات المنزليّة. إسأل الصيدليّ عن كيفيّة التخلّص من الأدوية التي لم تعد تستعملها. فمن شأن هذه الإجراءات المساعدة في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>المادة الفعالة هي:</strong></p><p dir="RTL">مترونيدازول...........................................................................................................................500.00 ملغ</p><p dir="RTL">للقرص الواحد المغلّف بطبقة رقيقة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكوّنات الأخرى هي:</p><p dir="RTL">نشا القمح، بوفيدون كاي 30، ستيارات المغنيزيوم، هبروميلوز، ماكروغول 20000 .</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يأتي هذا الدواء على شكل أقراص مغلّفة بطبقة رقيقة</p><p dir="RTL">علب من 4 أقراص أو 14 قرصًا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة حاملة رخصة التسويق </strong></p><p dir="RTL">Sanofi-Aventis France</p><p dir="RTL">82 Avenue Raspail</p><p dir="RTL">94250&nbsp;Gentilly</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركة المشغّلة</strong></p><p dir="RTL">Sanofi-Aventis France</p><p dir="RTL">82 Avenue Raspail</p><p dir="RTL">94250&nbsp;Gentilly , France</p><p>&nbsp;</p><p dir="RTL"><strong>الشركة المصنّعة</strong></p><p dir="RTL">Sanofi-Aventis S.A.</p><p dir="RTL">Ctra. Ctra. C-35 (La Batll&ograve;ria-Hostalric, km. 63.09)</p><p dir="RTL">Riells I Viabrea</p><p dir="RTL">17404 Gerona, Spain</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التعبئة الثانويّة</strong></p><p dir="RTL"><strong>Sanofi Aventis Arabia Co, Ltd</strong></p><p dir="RTL">Industrial Valley Phase 1A St.</p><p dir="RTL">KAEC, Abdullahndustrial Valley</p><p dir="RTL">Phase 1A St, Rabigh,, Saudi Arabia</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ابريل 2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                FLAGYL 500 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Metronidazole ............................................................................................................................ 500.00 mg
For one film-coated tablet.
Excipient with known effect: wheat starch (containing gluten) (see section 4.4).
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>They are based on the antiparasitic and antibacterial activity of metronidazole and its pharmacokinetic characteristics. They take into account the clinical studies on the medicinal product, as well as its place in the range of currently available anti-infective products.<br />They are limited to infections due to germs defined as sensitive:<br />&bull; Amoebiasis,<br />&bull; Urogenital trichomoniasis,<br />&bull; Non-specific vaginitis,<br />&bull; Giardiasis,<br />&bull; Curative treatment of medical-surgical infections with sensitive anaerobic germs,<br />&bull; Switch from injectable curative treatments to infections with sensitive anaerobic bacteria.<br />The official recommendations on the proper use of antibacterial agents must be taken into account.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Posology</strong></u><br />&bull; Amoebiasis<br />o Adults<br />1.50 g daily as 3 divided doses.<br />o Children<br />30 to 40 mg/kg/day in 3 divided doses.<br />In patients with hepatic amoebic liver abscess, stage, abscess drainage should be performed in conjunction with metronidazole therapy.<br />Treatment duration is 7 consecutive days.<br />&bull; Trichomoniasis<br />o In women (urethritis and vaginitis due to Trichomonas), single dose treatment of 2 g in a single dose (4 tablets).<br />It is important that the partner be treated concomitantly, regardless of whether there are clinical signs of Trichomonas vaginalis infestation, even without a positive laboratory test result.<br />&bull; Giardiasis<br />o Adults<br />0.750 g to 1 g/day for 5 consecutive days.<br />o Children:<br />From 10 to 15 years of age: 500 mg/day.<br />&bull; Non-specific vaginitis<br />500 mg twice daily for 7 days.<br />The patient&rsquo;s partner should be treated at the same time.<br />&bull; Treatment of infections caused by anaerobes<br />(as first-line or replacement treatment)<br />o Adults:<br />1 to 1.5 g/day.<br />o Children:<br />20 to 30 mg/kg/day.<br /><u><strong>Method of administration</strong></u><br />Oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to metronidazole or the imidazole family or to any of the excipients listed in section 6.1.
• Patients with a wheat allergy (other than coeliac disease) (see section 4.4).
• Children under 6 years of age, due to the pharmaceutical form (see section 4.4).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Hypersensitivity/skin and appendages</strong></u><br />Allergic reactions, including anaphylactic shock, can occur and may be life-threatening (see section 4.8). In these cases, metronidazole should be discontinued and appropriate medical treatment should be implemented.<br />The onset of an acute generalised erythema associated with pustules at the beginning of treatment should lead to the suspicion of acute generalised exanthematous pustulosis (see section 4.8); this requires therapy cessation and contraindicates any new administration of metronidazole, alone or combined.<br />Cases of severe skin reaction including Stevens-Johnson syndrome, Lyell&rsquo;s Syndrome and Acute Generalised Exanthematous Pustulosis (AGEP) have been reported with metronidazole. Patients must be informed of the signs and symptoms and the skin should be closely monitored.<br />The occurrence of signs or symptoms of Stevens-Johnson syndrome, Lyell&rsquo;s Syndrome (e.g., progressive rash often with blisters or mucous membrane injuries) or AGEP (acute generalised exanthematous pustulosis) (see section 4.8) requires therapy cessation and contraindicates any new administration of metronidazole, alone or combined.<br /><u><strong>Central nervous system</strong></u><br />If symptoms suggestive of encephalopathy or cerebellar syndrome occur (for example, ataxia, dysarthria, gait disturbance, nystagmus, tremor, vertigo, confusion, convulsions, peripheral sensory neuropathy, headache (see section 4.8)), the patient&rsquo;s management must be immediately reassessed, and the metronidazole treatment must be discontinued.<br />Cases of encephalopathy have been reported during post-marketing monitoring of this medicine. Cases of MRI changes associated with encephalopathy have also been observed (see section 4.8). The observed lesions are localised more frequently in the cerebellum (particularly in the dentate nucleus) and in the splenium of the corpus callosum. Most encephalopathy cases and MRI changes are reversible upon treatment discontinuation. Rare cases with fatal outcomes have been reported.<br />Signs suggestive of encephalopathy or deterioration in patients with central neurological conditions should be monitored.<br />In cases of aseptic meningitis being treated with metronidazole, reinitiating treatment is not recommended or must be subject to an assessment of the benefit/risk ratio in the case of a severe infection.<br /><u><strong>Peripheral nervous system</strong></u><br />Signs suggestive of peripheral neuropathy, especially in the case of prolonged treatment or in patients with severe, chronic or progressive peripheral neurological conditions, should be monitored.<br /><u><strong>Psychiatric disorders</strong></u><br />Psychotic reactions with possible risky behaviour for the patient can occur starting from the first doses of the treatment, particularly in patients with psychiatric history (see section 4.8). Metronidazole should therefore be discontinued, the doctor informed and the necessary therapeutic measures taken immediately.<br /><u><strong>Blood disorders</strong></u><br />In the case of history of blood disorders, with a high-dose treatment and/or prolonged treatment, it is recommended to perform regular blood tests, especially differential white blood cell count.<br />In the case of leukopaenia, treatment continuation depends on the severity of the infection.<br />Excipient with known effect Wheat starch (containing gluten)<br />This medicinal product contains only very low levels of gluten (from wheat starch) and is very unlikely to cause problems if you have coeliac disease.<br />One tablet contains no more than 16.43 micrograms of gluten.<br />Patients with an allergy to wheat (different from coeliac disease) must not take this medicinal product (see section 4.3).<br /><u><strong>Paediatric population</strong></u><br />The taking of tablets is contraindicated in children under 6 years of age because they may cause choking. Other metronidazole-based presentations exist that are suitable for young children.<br /><u><strong>Interaction with other medicinal products</strong></u><br />The concomitant use of metronidazole and alcohol is not recommended (see section 4.5).<br />The concomitant use of metronidazole and busulfan is not recommended (see section 4.5).<br />The concomitant use of metronidazole and disulfiram is not recommended (see section 4.5).<br /><u><strong>Interference with paraclinical examinations and laboratory tests</strong></u><br />Metronidazole may immobilise treponemes and thus lead to false positive Nelson test results.<br />Metronidazole may interfere with certain types of blood tests (alanine aminotransferase [ALT], aspartate aminotransferase [AST], lactate dehydrogenase [LDH], triglycerides, glucose), which may lead to a false negative or an abnormally low result. These analytical methods are based on a decrease in ultraviolet absorbance, which occurs when hydrogenated nicotinamide adenine dinucleotide (NADH) is oxidised to nicotinamide adenine dinucleotide (NAD). This interference is due to the similarity of the absorption peaks of NADH (340 nm) and metronidazole (322 nm) at pH 7.<br /><u><strong>Hepatotoxicity in patients with Cockayne Syndrome</strong></u><br />Cases of severe hepatoxicity/acute hepatic failure, including cases resulting in a fatal outcome with a very fast onset after initiation of the treatment in patients with Cockayne syndrome, have been reported with products containing metronidazole for systemic use. In this population, metronidazole should not be used unless the benefit is considered to outweigh the risk and no alternative treatment is available. Hepatic function tests must be performed before the start of treatment, throughout the treatment and after the end of treatment, until the hepatic function is within a normal range or until the initial values are obtained. If the hepatic function tests become significantly increased during the treatment, the medicinal product should be discontinued.<br />Patients with Cockayne syndrome should be advised to immediately report all symptoms of potential hepatic lesions to their doctor and to stop taking metronidazole (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Antabuse reaction</strong></u><br />Many medicinal products trigger an antabuse effect with alcohol and their concomitant use with alcohol is not advisable.<br /><u><strong>Inadvisable combinations</strong></u><br /><strong>+ Alcohol (beverage or excipient)</strong><br />An antabuse effect (hot flushes, erythema, vomiting, tachycardia) may occur. Consuming alcoholic beverages and other medicinal products containing alcohol should be avoided. Alcoholic beverages or medicinal products containing alcohol should not be ingested again until medicinal products have been completely eliminated from the body. The half-life should be used as a reference.<br /><strong>+ Busulfan</strong><br />When co-administered with high busulfan doses: metronidazole causes a two-fold increase in plasma busulfan concentrations.<br /><strong>+ Disulfiram</strong><br />There is a risk of acute psychotic episodes or confusion, reversible on discontinuation of the medicinal product combination.<br /><strong>+ Medicinal products causing QT interval prolongation</strong><br />Cases of QT interval prolongation have been reported, particularly when metronidazole is administered with medicinal products that may prolong the QT interval.<br /><u><strong>Combinations requiring precautions for use</strong></u><br /><strong>+ Enzyme-inducing anticonvulsants</strong><br />Decreased plasma concentrations of metronidazole can occur due to increased liver metabolism by the inducer.<br />Clinical monitoring is required and the metronidazole dose may need to be adjusted during and after treatment with the inducer.<br /><strong>+ Rifampicin</strong><br />Decreased plasma concentrations of metronidazole can occur due to increased liver metabolism by rifampicin.<br />Clinical monitoring is required and the metronidazole dose may need to be adjusted during and after treatment with rifampicin.<br /><strong>+ Lithium</strong><br />Increased blood lithium levels can occur, which can reach toxic levels with signs of lithium overdose.<br />Strict monitoring of blood lithium levels should be performed and the lithium dose adjusted if necessary.<br /><u><strong>Combinations to be taken into account</strong></u><br />Fluorouracil (and by extrapolation, tegafur and capecitabine)<br />Increased fluorouracil toxicity can occur due to decreased clearance.<br /><u><strong>Specific issues related to INR imbalance:</strong></u><br />Numerous cases of increased oral anticoagulant activity have been reported in patients receiving antibiotics. The severity of the infection or inflammation, age and general health status of the patient appear to be risk factors. Under these circumstances, it is difficult to distinguish between the role of the infectious disease and that of its treatment in the onset of changes in the INR. However, certain classes of antibiotics are more involved, particularly fluoroquinolones, macrolides, cyclins, cotrimoxazole and certain cephalosporins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Pregnancy</strong></u><br />Animal studies do not indicate any teratogenic effect. As there is no teratogenic effect in animals, no malformative effect is expected in humans. To date, substances which cause malformations in humans have been found to be teratogenic in animals during well-conducted studies on two species.<br />In clinical practice, the analysis of a high number of exposed pregnancies did not clearly reveal any teratogenic or particular foetotoxic effect of metronidazole. However, only epidemiological studies would make it possible to rule out a risk. Therefore, metronidazole can be prescribed during pregnancy if needed.<br /><u><strong>Breast-feeding</strong></u><br />Metronidazole is excreted in human milk and should not be used during breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>It is necessary to warn patients about the potential risk of vertigo, confusion, hallucinations, seizures, or vision disorders and advise them not to drive or use machines if this type of disorder occurs.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Blood and lymphatic system disorders</strong></u><br />&bull; Neutropenia, agranulocytosis, thrombocytopaenia.<br />Cardiac disorders<br />&bull; Not known: Cases of QT interval prolongation have been reported, particularly when metronidazole is administered with medicinal products that may prolong the QT interval.<br /><u><strong>Psychiatric disorders</strong></u><br />&bull; Hallucinations,<br />&bull; Psychotic reactions with paranoia and/or delirium that, in isolated cases, can be accompanied by suicidal ideation or suicide attempts (see section 4.4),<br />&bull; Depressed mood.<br /><u><strong>Nervous system disorders</strong></u><br />&bull; Peripheral sensory neuropathy,<br />&bull; Headaches,<br />&bull; Dizziness,<br />&bull; Confusion,<br />&bull; Seizures,<br />&bull; Encephalopathy that may be associated with MRI changes are usually reversible upon therapy cessation. Rare cases with fatal outcomes have been reported (see section 4.4),<br />&bull; Subacute cerebellar syndrome (ataxia, dysarthria, gait disorder, nystagmus, tremors) (see section 4.4),<br />&bull; Aseptic meningitis (see section 4.4).<br /><u><strong>Eye disorders</strong></u><br />&bull; Transient vision disorders such as blurred vision, diplopia, myopia, reduced visual acuity, impaired colour vision,<br />&bull; Neuropathy/optic neuritis.<br /><u><strong>Gastrointestinal disorders</strong></u><br />&bull; Mild gastrointestinal disorders (epigastric pain, nausea, vomiting, diarrhoea),<br />&bull; Glossitis with the feeling of a dry mouth, stomatitis, taste disorders, anorexia,<br />&bull; Pancreatitis reversible upon treatment discontinuation,<br />&bull; Discolouration or change in the tongue&rsquo;s appearance (mycosis).<br /><u><strong>Hepatobiliary disorders</strong></u><br />&bull; Elevated liver enzymes (AST, ALT, alkaline phosphatase), very rare cases of acute hepatic impairment of a cytolytic (sometimes icteric), cholestatic or mixed nature. Isolated cases of hepatocellular insufficiency possibly requiring liver transplant have been reported.<br />&bull; Cases of severe irreversible hepatotoxicity/acute hepatic failure, including cases resulting in a fatal outcome with a very fast onset after initiation of the systemic use of metronidazole, have been reported in patients with Cockayne syndrome (see section 4.4).<br /><u><strong>Skin and subcutaneous tissue disorders</strong></u><br />&bull; Flushing, pruritus, skin rash, occasionally accompanied with fever,<br />&bull; Urticaria, angioedema, anaphylactic shock (see section 4.4),<br />&bull; Very rare cases of acute generalised exanthematous pustulosis (see section 4.4),<br />&bull; Lyell&rsquo;s syndrome,<br />&bull; Stevens-Johnson syndrome,<br />&bull; Fixed drug eruption.<br /><u><strong>Other effects</strong></u><br />&bull; Reddish-brown coloured urine due to the water-soluble pigments from metabolism of the medicinal product.<br /><strong><u>Reporting of suspected adverse reactions</u><br />&bull; Saudi Arabia:</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p><strong><u>&bull; Sanofi- Pharmacovigilance: KSA_Pharmacovigilance@sanofi.com</u></strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Administration of up to 12 g as a single dose has been reported in cases of attempted suicide and accidental overdose.<br />The symptoms were limited to vomiting, ataxia and mild disorientation. There is no specific antidote to metronidazole overdose. If massive overdose occurs, symptomatic treatment should be instituted.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group: anti-parasitic antibacterial antibiotics of the nitro-5-imidazoles family, ATC code: J01XD01 &ndash; P01AB01 (J: Anti-infectives, other antibacterials-imidazole derivatives - P: antiprotozoals, medicines against amoebiasis and other protozoan derivatives of metronidazole)</strong><br />The MIC breakpoints differentiating susceptible from intermediate strains and intermediate from resistant strains are as follows: S &le;4 mg/l and R &gt;4 mg/l.<br />The prevalence of acquired resistance in certain species can vary geographically and over time. It is therefore useful to have local information on the prevalence of resistance, especially in treating severe infections. These data are only guidelines indicating the probability of susceptibility of a bacterial strain to this antibiotic.<br />When the variability of prevalence of resistance of a bacterial species is known in France, it is indicated in the table below:<br /><img src="data:image/png;base64,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" alt="" width="804" height="720" vspace="0" hspace="0" border="0" style="width:804px;height:720px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /><br /><img src="data:image/png;base64,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" alt="" width="802" height="175" vspace="0" hspace="0" border="0" style="width:802px;height:175px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Absorption</strong></u><br />After oral administration, metronidazole is rapidly absorbed, at least 80% in one hour. The serum peak levels obtained after oral administration are similar to those obtained after the intravenous administration of equivalent doses.<br />The bioavailability via oral use is 100%. This is not significantly affected by simultaneous food intake.<br /><u><strong>Distribution</strong></u><br />&bull; Approximately 1 hour after the single dose of 500 mg, the maximum serum concentration reached is 10 micrograms/ml on average. After 3 hours, the average serum concentration is 13.5 micrograms/ml.<br />&bull; The plasma half-life is 8 to 10 hours.<br />&bull; The blood protein binding is low: less than 20%.<br />&bull; The apparent volume of distribution is high, around 40 l (i.e., 0.65 l/kg).<br />&bull; Metronidazole is rapidly and significantly distributed in the lungs, kidneys, liver, skin, bile, CSF, saliva, semen and vaginal discharge, with concentrations similar to serum levels.<br />Metronidazole crosses the placental barrier and is excreted in breast milk.<br /><u><strong>Biotransformation</strong></u><br />Metabolism is essentially hepatic. Two key compounds are formed by oxidation:<br />&bull; The &ldquo;alcohol&rdquo; metabolite, major metabolite, with antibacterial activity against anaerobic bacteria that is approximately 30% that of metronidazole and an elimination half-life of approximately 11 hours,<br />&bull; The &ldquo;acid&rdquo; metabolite, in small quantity, with antibacterial activity of approximately 5% that of metronidazole.<br /><u><strong>Excretion</strong></u><br />High concentrations of metronidazole can be found in the liver and bile. Low concentrations of the medicinal product are found in the colon. Metronidazole is poorly excreted in the faeces. Excretion is mainly via the urinary route, as metronidazole and its oxidized metabolites found in urine account for approximately 35% to 65% of the administered dose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Wheat starch, povidone K30, magnesium stearate, hypromellose, macrogol 20000.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable. <sup>&nbsp;</sup></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store the blisters in the outer packaging, protected from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4 tablets in thermoformed blisters (PVC/Aluminium).<br />14 tablets in thermoformed blisters (PVC/Aluminium).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SANOFI-AVENTIS FRANCE
82 AVENUE RASPAIL
94250 GENTILLY

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>